Učitavanje...
Improving and maintaining responses in pediatric B-ALL CAR-T therapy
CAR T therapy has heralded a new era in the treatment of acute lymphoblastic leukemia (ALL) and other hematologic malignancies. In this autologous immunotherapy, patient derived T cells are genetically engineered and then infused back to kill the leukemia cells. The observed response rates in ALL ar...
Spremljeno u:
| Izdano u: | Cancer J |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130572/ https://ncbi.nlm.nih.gov/pubmed/33750075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000513 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|